Inari Medical - 500 Beiträge pro Seite

[HenryScheinulf]

liegt in einer Schublade mit z.B. * www.penumbrainc.com *
* www.shockwavemedical.com * www.silkroadmedical.com *

Börsengang im Mai: www.inarimedical.com
www.inarimedical.com/in-the-news * https://ir.inarimedical.com/node/6646/pdf

[Rastelly]

Inari Medical Reports

Höhepunkte des dritten Quartals :

• Rekordvolumen im dritten Quartal, behandelt über 3.700 Patienten

• Im dritten Quartal 2020 wurde ein Umsatz von 38,7 Mio. USD ausgewiesen, ein Anstieg von 172% gegenüber dem Vorjahresquartal und ein sequenzieller Anstieg von 52% gegenüber dem zweiten Quartal

• Präsentierte die ersten 230 Patienten aus unserer FLASH-Datenbank als späte klinische Studie bei TCT

• Beendete das Quartal mit 168,0 Mio. USD an liquiden Mitteln

Des Umsatz betrug $ 38,7 Mio. für das dritte Quartal 2020 im Vergleich zu $ 25,4 Mio. für das vorangegangene Quartal und $ 14,2 Mio. für das dritte Quartal 2019. Der Anstieg aus dem vergangenen Jahr gefahren wurde durch fortgesetzte US kommerzielle Expansion und erhöhte Produktannahme.

Der Bruttogewinn für das dritte Quartal 2020 betrug 35,5 Mio. USD gegenüber 12,7 Mio. USD für das dritte Quartal 2019. Die Bruttomarge stieg im dritten Quartal 2020 leicht auf 91,7%, verglichen mit 89,4% im Vorjahresquartal.

Die Betriebskosten beliefen sich im dritten Quartal 2020 auf 28,3 Mio. USD gegenüber 11,8 Mio. USD im Vorjahresquartal.

Bisher sucht die Aktie noch Ihren Wert, der Markt wird den Einstiegspunkt zeigen !!

https://www.fool.com/investing/2020/10/24/why-i-just-bought-…

https://finance.yahoo.com/news/inari-medical-reports-third-q…

Gruss RS

[flying.kangaroo]

Antwort auf Beitrag Nr.: 64.027.338 von HenryScheinulf am 16.06.20 02:53:10

Quillt deine Schublade schon über?

Preliminary unaudited revenue is expected to be in the range of $47.9 million to $48.9 million in the fourth quarter of 2020, a 141% to 146% increase over the prior year period and 24% to 26% increase over the third quarter of 2020.
The company completed approximately 4,600 procedures in the fourth quarter, a 156% increase over the prior year period and a 24% increase over the third quarter of 2020.
https://www.globenewswire.com/news-release/2021/01/13/215786…

Der Umsatz in Q4 entspricht dem Umsatz vom Gesamtjahr 2019!

[gerrard87]

COVID-Stock?!

Why did I get out of Inari? And what did I mean when I referred to Inari’s extreme caution, hesitation, negativity, and worry? Well, they had previously been talking about about how Covid had been a headwind for them, as their people couldn’t get into the hospital to sell to new physicians, and everyone was too busy with Covid patients to deal with them.

Now that Covid seemed over, instead of being elated, they were warning that the hospitals are now full with people who had been putting off tests and procedures during Covid. In other words they weren’t seeing the big tailwind they had been expecting. They wouldn’t even give guidance for the June quarter that they were already in, although they were half way through it in mid-May, and they gave full year guidance that was just a little over four times the March quarter’s revenue. I also heard from doctor friends that many hospitals are in a bad financial situation now due to Covid. This may lead to hospital administrators being unwilling to pay for Inari products which are four or five times more expensive, even if they do work better. All in all it seemed too complicated for me. It may all turn out to be a false alarm. They may be just super-duper cautious. That’s very possible. But I certainly wasn’t the only one who read it the way I did. The price dropped about 35% and almost $40...

[gerrard87]

Antwort auf Beitrag Nr.: 68.640.067 von gerrard87 am 29.06.21 12:50:13

Und es hat sich bewahrheitet was ich angekündigt habe...COVID hat zum Umsatz beigetragen, angeblich nur 15%...
Die Aktie wird meiner Meinung stark abgestraft aufgrund des intransparenten Managments, welches bei jedem vorherigen CALL gesagt haben, dass COVID nicht zum Umsatz beiträgt und es eher kontraproduktiv .... sowas mag die Börse gar nicht, das Managment muss hier noch einiges lernen...

Ich habe übrigens rechtzeitig verkauft!

Zitat von gerrard87: Why did I get out of Inari? And what did I mean when I referred to Inari’s extreme caution, hesitation, negativity, and worry? Well, they had previously been talking about about how Covid had been a headwind for them, as their people couldn’t get into the hospital to sell to new physicians, and everyone was too busy with Covid patients to deal with them.

Now that Covid seemed over, instead of being elated, they were warning that the hospitals are now full with people who had been putting off tests and procedures during Covid. In other words they weren’t seeing the big tailwind they had been expecting. They wouldn’t even give guidance for the June quarter that they were already in, although they were half way through it in mid-May, and they gave full year guidance that was just a little over four times the March quarter’s revenue. I also heard from doctor friends that many hospitals are in a bad financial situation now due to Covid. This may lead to hospital administrators being unwilling to pay for Inari products which are four or five times more expensive, even if they do work better. All in all it seemed too complicated for me. It may all turn out to be a false alarm. They may be just super-duper cautious. That’s very possible. But I certainly wasn’t the only one who read it the way I did. The price dropped about 35% and almost $40...

[gerrard87]

Und noch noch ein neuer Wettbewerber

https://seekingalpha.com/news/3736745-abbott-acquires-medica…

ABT ist eine Macht und eines der besten geführten Unternehmen in der US-Geschichte.